This website uses cookies to enhance your browsing experience, improve site performance, and gather analytics. By selecting 'Accept,' you consent to these cookies as described in our Privacy Policy.

Logo

Performance Comparison of the 25 Gauge 20,000cpm HYPERVIT Dual Blade vs. 10,000cpm ULTRAVIT Vitrectomy Cutter

Sponsored by The University of Hong Kong

About this trial

Last updated 3 years ago

Study ID

20K

Status

Completed

Type

Interventional

Phase

N/A

Placebo

No

Accepting

18+ Years
All Sexes

Trial Timing

Ended 3 years ago

What is this trial about?

This prospective randomised controlled trial will be conducted to investigate that increasing the vitrectomy cutting rate from 10,000 cut/min to 20,000 cut/min will result more efficiency and shorter core vitrectomy time, and it is equally safe as compared to the current 10,000 cut/min. We plan to target the patients undergoing for vitrectomy for common vitreoretinal pathology. Our plan is to conduct a randomised study with 2 arms, one with the higher cutting rate (20,000 cut/min) versus a second arm using the existing system 10,000 cuts/min.

What are the participation requirements?

Inclusion Criteria

* Patient over 18 years of age who are undergoing vitrectomy for the following conditions:

* Macular hole
* Epimacular membrane
* Vitreous hemorrhage
* Primary retinal detachment

Exclusion Criteria

* Patient who is

* unable to give proper consent
* previous vitrectomy or scleral buckle surgery
* cases requiring silicone oil tamponed
* undergoing repeated retinal detachment surgery
* undergoing surgery for tractional diabetic retinopathy